Unwarranted Clinical Variation refers to patient care that differs in ways that are not in keeping with national policy and clinical best practice, or reflect the needs and choices of patients. At Aqua, we are committed to reducing Unwarranted Clinical Variation by improving the reliability, quality and experience of health and care for people in the North West and beyond. We aim to do this by using validated clinical datasets, quality improvement approaches along with building governance, clinical leadership and data literacy within organisations.
The Advancing Quality (AQ) programme is our flagship Unwarranted Clinical Variation programme, and is the longest running improvement programme in the NHS, established in 2008. Data is at the heart of what we do with our AQ programme, and plays a key part in helping us identify the opportunities to improve care quality.
We currently support organisations improve the reliability of care and reduce unwarranted clinical variation across six clinical focus areas: Acute Kidney Injury, Decompensated Liver Disease, Community Acquired Pneumonia, Hospital Acquired Pneumonia, Elective Hip and Knee Replacement and Sepsis.